🌿 Traditional Knowledge — Protecting India's Ancient Wisdom
Meaning · Types & Examples · Biopiracy · Turmeric & Neem Cases · TKDL · Defensive & Positive Protection · WIPO Treaty May 2024 · Nagoya Protocol · Biological Diversity Act · AYUSH · NEP 2020 · PYQs & MCQs
Turmeric (Curcuma longa) — at the centre of India's most famous biopiracy case. In 1995, the US Patent Office granted a patent for turmeric's wound-healing properties, ignoring thousands of years of documented Indian traditional use. India successfully challenged and revoked this patent using the TKDL database. (Source: Wikimedia Commons)
Sacred Groves — one of the most powerful examples of traditional knowledge for biodiversity conservation. Communities like the Bishnois of Rajasthan and Maldhari tribe of Gujarat have conserved forests through sacred traditions for centuries, often more effectively than modern conservation methods. (Source: Wikimedia Commons)
🌐 Domains of Traditional Knowledge
- Oral transmission: Passed through stories, songs, rituals — NOT written documentation (which makes it vulnerable)
- Collective ownership: Belongs to the entire community, not an individual. Conflicts with IP systems that recognise individual/corporate ownership
- Dynamic: Not static — communities continuously innovate and adapt TK to changing conditions
- Holistic: Integrates ecological, spiritual, social, and practical knowledge — not compartmentalised like Western science
- Contextual: Deeply tied to specific ecosystems and cultures — may not work when transplanted to other contexts without community knowledge
⚠ Major Threats to Traditional Knowledge
🏭 How Biopiracy Works
Step 2: Researcher extracts the active compound in the lab, slightly modifies the formulation
Step 3: Corporation files a patent at a foreign patent office (e.g., USPTO, EPO) claiming the "invention"
Step 4: Patent granted (patent examiner unaware of traditional prior art)
Step 5: Corporation now charges royalties even in India — the country of origin!
Step 6: India must spend time and money challenging the patent in foreign courts
Prevention: TKDL provides prior art documentation that patent examiners can access, preventing Step 4.
🔴 Famous Biopiracy Cases — India's Hard-Won Battles
India's response: India (CSIR) challenged the patent, providing documentary evidence from ancient Ayurvedic texts (including Sanskrit shlokas from medieval texts describing turmeric's wound-healing properties) showing this was prior art.
Outcome: The USPTO revoked the patent in 1997. First successful challenge by a developing country against biopiracy using documentary TK evidence.
India's response: India, along with the International Federation of Organic Agriculture Movements (IFOAM) and Dr. Vandana Shiva (India activist), challenged the patent citing centuries of Indian traditional use of neem for pest control and medicinal purposes. Traditional knowledge from rural India — neem as the "village pharmacy" — was documented as prior art.
Outcome: EPO revoked the patent in 2000, upheld on appeal in 2005. A landmark victory for India's biodiversity sovereignty. The Neem case is also a key UPSC case study on traditional knowledge, IPR, and biopiracy.
India's response: India challenged the patent at USPTO. After sustained diplomatic and legal pressure, RiceTec withdrew several of the broadest patent claims.
Outcome: Partial victory — broader claims revoked but some narrower claims survived. This led India to register Basmati as a Geographical Indication (GI) in India, strengthening protection. Highlights the need for international GI protection and the WIPO GRATK Treaty.
Significance: First case in India where a company faced criminal proceedings for biopiracy under the Biological Diversity Act, 2002. Mahyco became India's first commercial entity to be accused of bio-piracy of local germplasm. Demonstrates that India's domestic law (Biological Diversity Act) can be used against biopiracy even by Indian-based companies.
🛡 Two Pillars of TK Protection
How:
• Document TK as prior art so patents cannot be granted for already-known knowledge (TKDL)
• Modify IP laws to require disclosure of origin in patent applications
• Expand WIPO's Patent Cooperation Treaty Minimum Documentation to include TK databases
• Amend patent rules to make TK non-patentable prior art in all jurisdictions
Example: TKDL — India's database of 34 million pages of traditional medical formulations that patent examiners worldwide can search to find prior art.
How:
• Community IP rights — formal recognition of collective ownership
• Benefit-sharing agreements — if a company profits from TK, community must share
• Geographical Indications (GIs) — legal recognition of regional products (Darjeeling tea, Mysore silk)
• Plant variety protection — farmers' rights to traditional seed varieties
Example: Nagoya Protocol — requires companies using TK to enter Access and Benefit-Sharing (ABS) agreements with source communities.
What it contains: A comprehensive prior art database of Indian traditional medical knowledge — structured, searchable, and available to patent offices worldwide
Scale: 34 million pages of formatted information on approximately 2,260,000 medicinal formulations
Languages: Available in English, French, German, Spanish, and Japanese — accessible to patent examiners in all major patent offices
Sources: Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Siddha, Unani texts
• In Europe alone: 36 patent applications cancelled or withdrawn within 2 years
• 200+ patent applications globally rejected or withdrawn
• Colgate-Palmolive: 2 oral composition patents blocked
• Turmeric, neem: Patents revoked using TKDL evidence
• Yoga postures: Bogus patents challenged
• WIPO adopted India's TKRC (Traditional Knowledge Resource Classification) into its International Patent Classification system
| Initiative | Year | Key Details |
|---|---|---|
| Biological Diversity Act (BDA) | 2002 | Mandates Biodiversity Management Committees (BMCs) at all local body levels. BMCs prepare People's Biodiversity Registers (PBR) documenting local biological resources and associated TK. Requires prior approval of National Biodiversity Authority (NBA) for commercial access to India's biological resources. Used in Bt Brinjal bio-piracy case against Mahyco. |
| Ministry of AYUSH | 2014 | Dedicated ministry (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homeopathy) for promotion and propagation of India's traditional medicine systems. Integrates TK into mainstream healthcare. Managed the dramatic global interest in Ayurveda during COVID-19 (Ashwagandha, Giloy, Chyawanprash surge in demand). |
| National IPR Policy | 2016 | Explicitly acknowledges traditional knowledge and "less-visible intellectual property generators" — indigenous communities. Recognises TK as an IP asset that can be commercially monetised while preserving community rights. Calls for converting TK into IP assets for economic benefit-sharing. |
| National Innovation Foundation (NIF) | 2000 | Department of Science and Technology (DST) initiative. Prevents biopiracy AND facilitates IPR protection for grassroots innovations based on TK and ancestral knowledge. Established through the Honey Bee Network (Prof. Anil Gupta, IIM Ahmedabad). Databases innovations by ordinary people — farmers, tribal communities. |
| Geographical Indications (GI) Registry | 1999 onwards | GI tags protect region-specific TK-based products: Darjeeling Tea, Mysore Silk, Kancheepuram Silk, Pashmina, Alphonso Mango, Basmati rice (under process). Over 400 GI tags in India — many protecting traditional craft and agricultural knowledge. Prevents misappropriation by non-origin producers. |
| Indian Knowledge Systems (IKS) | 2020 (MoE) | Innovative cell at AICTE under Ministry of Education. Advances interdisciplinary study of all facets of IKS. Centre of Excellence for IKS to be set up at IIT Kharagpur. Integrates traditional knowledge into formal education curricula. |
| National Education Policy (NEP) 2020 | 2020 | Explicitly includes Indigenous Traditional Knowledge (ITK) as a vision component. Refers to TK as "sustainable and striving for welfare of all." Mandates integration of local and traditional knowledge into school and university curricula. |
| Biological Diversity (Amendment) Act | 2023 | Amended the BDA 2002 to streamline access procedures for AYUSH practitioners and codified medicine users. However, critics argue it potentially reduces community rights and weakens benefit-sharing provisions — a live debate in TK protection. |
Historic significance: The 27th WIPO treaty; first in over 10 years. Negotiations began in 1999 (Colombia's proposal) — took 25 years to reach adoption. Adopted by 150+ countries with consensus including major developed nations.
Key provision — Mandatory Disclosure: Patent applicants must disclose the country of origin or source of genetic resources and the indigenous peoples or local community that provided associated TK, when the claimed invention is based on those GRs or TK.
Entry into force: Requires ratification by 15 WIPO member states. Still pending.
| Instrument | Year | Body | TK Relevance |
|---|---|---|---|
| Convention on Biological Diversity (CBD) | 1992 (India: 1994) | UNEP / UN | Acknowledges indigenous communities' ties to biological resources. Article 8(j) requires parties to "respect, preserve and maintain knowledge, innovations and practices of indigenous and local communities." Established framework for Access and Benefit Sharing (ABS). |
| Nagoya Protocol on ABS | 2010 (India: 2012) | CBD Secretariat | Binding international agreement on ABS. Requires companies accessing genetic resources and TK to: (1) Obtain Prior Informed Consent (PIC) from source country/community; (2) Share benefits with source community through Mutually Agreed Terms (MAT). India has implemented via Biological Diversity Act 2002 and amendments. |
| UNDRIP | 2007 | UN General Assembly | UN Declaration on Rights of Indigenous Peoples. Article 31: Indigenous peoples have the right to maintain, control, protect and develop their cultural heritage, traditional knowledge and traditional cultural expressions. India supported UNDRIP. |
| TRIPS Agreement | 1994 | WTO | Trade-Related Aspects of Intellectual Property Rights. Article 27.3(b) allows WTO members to exclude plants/animals from patentability — India uses this. However, TRIPS does not explicitly protect TK, creating a "TRIPS-CBD conflict" that India actively advocates to resolve through mandatory disclosure requirements. |
| UNESCO LINKS Programme | Ongoing | UNESCO | Local and Indigenous Knowledge Systems (LINKS). Integrates TK into global climate science and policy. Works at local, national, and international levels to ensure TK informs climate adaptation and mitigation strategies. Acknowledges TK as crucial for understanding local environmental change. |
| WIPO Intergovernmental Committee (IGC) | 2000–ongoing | WIPO | Forum negotiating international instruments for protection of TK, genetic resources, and traditional cultural expressions. Led to the May 2024 WIPO GRATK Treaty. Still negotiating separate instruments for TK and TCEs (separate from GRs). |
| WIPO GRATK Treaty | May 24, 2024 | WIPO | Treaty on IP, Genetic Resources and Associated Traditional Knowledge. Mandatory patent disclosure of GR/TK source. First WIPO treaty to address this interface; first to include provisions for Indigenous Peoples and local communities. Requires 15 ratifications to enter force. |
- It was established by the Ministry of External Affairs jointly with the Council of Scientific and Industrial Research.
- It contains information from Ayurveda, Unani, and Siddha systems of medicine only.
- It serves as a tool to assist patent examiners of major intellectual property offices in carrying out prior art searches.
- a) 1 and 3 only
- b) 2 and 3 only
- c) 3 only ✓
- d) 1, 2 and 3
Statement 2 WRONG: TKDL covers Ayurveda, Unani, Siddha, and also Yoga and Naturopathy. It is not limited to three systems — it covers all documented traditional medical systems. Yoga postures have been specifically documented to prevent bogus patents by foreign entities.
Statement 3 CORRECT: TKDL is specifically designed as a "prior art tool" — its primary purpose is to give patent examiners in patent offices worldwide (USPTO, EPO, JPO, CIPO etc.) searchable access to India's documented TK, so they can verify whether a patent application claims something already known in Indian traditional knowledge.
Model Answer Framework:
- Introduction: Define TK — knowledge, skills, practices passed down generations. India = mega biodiversity hotspot with 7–8% global biodiversity and 2 million+ documented medicinal formulations. TK is both a cultural asset and an economic resource.
- Development contribution — Economic: AYUSH industry (₹18,000 crore+ market). GI-tagged products — Darjeeling tea, Mysore silk — premium export earnings. NIF's grassroots innovations commercialised. Biotourism potential of tribal knowledge.
- Development contribution — Agricultural: Traditional seed varieties (open pollinated) reduce dependency on costly hybrid seeds. Indigenous water harvesting addresses drought. Traditional pest management reduces chemical input costs.
- Development contribution — Health: Affordable primary healthcare — Ayurveda, Siddha, Unani cheaper than allopathic. Drug discovery (Artemisinin from traditional Chinese medicine, basis of malaria cure).
- Development contribution — Environment/SDGs: Sacred groves conserve biodiversity. TK-based climate adaptation. Indigenous land management.
- Protection mechanisms: TKDL (2001), BDA 2002, Nagoya Protocol, GI tags, NEP 2020, National IPR Policy 2016, WIPO GRATK Treaty 2024
- Challenges: Biopiracy, language erosion, urbanisation, lack of standalone TK law
- Way forward: Expand TKDL to tribal/folk knowledge; strengthen Biological Diversity Act; promote ABS frameworks; benefit-sharing with communities; AI-assisted TK documentation
- (a) It completely resolves the issue of biopiracy by making all patent claims on TK-based products null and void worldwide
- (b) It bans patent offices in developed countries from accepting applications related to natural compounds or traditional medicine
- (c) It is the first WIPO treaty to require mandatory patent disclosure of the country of origin of genetic resources and associated traditional knowledge, and the first WIPO treaty to include provisions specifically for Indigenous Peoples and local communities
- (d) It creates a global fund to compensate indigenous communities for all past biopiracy violations
1. Turmeric wound-healing patent (USA) — Successfully challenged and patent revoked by India
2. Neem-based fungicide patent (European Patent Office) — Patent upheld; India lost the challenge
3. Basmati rice varieties (USA, RiceTec) — All patent claims were fully revoked after India's challenge
Which of the above is/are correctly matched?
- (a) 1 only
- (b) 1 and 2 only
- (c) 2 and 3 only
- (d) 1, 2 and 3
- (a) Setting global emission reduction targets for greenhouse gases from agricultural practices
- (b) Access to genetic resources and traditional knowledge, and the fair and equitable sharing of benefits arising from their use with source countries and communities
- (c) Banning the trade of genetically modified organisms across international borders
- (d) Establishing a global fund for indigenous peoples' education and healthcare
- (a) The National Biodiversity Authority at the national level
- (b) Biodiversity Management Committees (BMCs) at local body levels, documenting local biological resources and associated traditional knowledge
- (c) The Ministry of Environment, Forest and Climate Change in partnership with state governments
- (d) The Council of Scientific and Industrial Research (CSIR) as part of the TKDL project
- (a) A legal dispute between India and the WTO over India's refusal to implement TRIPS standards for pharmaceutical patents
- (b) Disagreements between member states about whether traditional cultural expressions should be protected as trademarks or copyrights
- (c) The tension between TRIPS (which protects corporate IP rights and does not require disclosure of traditional knowledge sources in patent applications) and the CBD/Nagoya Protocol (which requires benefit-sharing and Prior Informed Consent when using genetic resources and TK)
- (d) A conflict between WIPO and WTO over who has jurisdiction to regulate biopiracy cases globally
| Topic | Key Facts to Remember |
|---|---|
| Definition | Knowledge, know-how, skills passed down generations within indigenous/local communities. Found in agriculture, medicine, ecology, arts, technology. Oral, collective, holistic, contextual — key features. |
| Biopiracy | Commercial exploitation of biological resources/TK without consent or benefit-sharing. Corporate "invention" of what indigenous communities already knew. Famous cases: Turmeric (USA, 1995 — revoked 1997), Neem (EPO, 1994 — revoked 2000/2005), Basmati (USA, 1997 — partial win), Bt Brinjal biopiracy (Mahyco, 2013 — first criminal prosecution in India). |
| Two Types of TK Protection | Defensive: Prevent unauthorised IP rights (TKDL, prior art). Positive: Empower TK holders with active rights (GIs, Nagoya Protocol ABS, community IP rights). |
| TKDL | Traditional Knowledge Digital Library. Established 2001. By AYUSH + CSIR. 34 million pages, 22 lakh medicinal formulations. Languages: English, French, German, Spanish, Japanese. 200+ patents blocked globally. WIPO adopted India's TKRC into International Patent Classification. Primary purpose: Prior art database for patent examiners. |
| Biological Diversity Act 2002 | BMCs at all local body levels → prepare People's Biodiversity Registers (PBRs). NBA (National Biodiversity Authority) for national-level access decisions. Used in Mahyco Bt brinjal bio-piracy case. Amended 2023 (controversy: may weaken community rights). |
| Nagoya Protocol | CBD supplementary agreement, 2010. Access and Benefit Sharing (ABS). Requires: Prior Informed Consent (PIC) + Mutually Agreed Terms (MAT). India ratified 2012. Implemented via BDA 2002. |
| WIPO GRATK Treaty 2024 | Adopted May 24, 2024. 27th WIPO treaty, first in 10 years. First treaty specifically for GRs and TK. First with provisions for Indigenous Peoples. Mandatory disclosure of GR/TK country of origin in patent applications. Needs 15 ratifications to enter force. "Significant win for India and Global South" (PIB). |
| India's Other Initiatives | Ministry of AYUSH (2014) · National IPR Policy 2016 · NIF (2000, Honey Bee Network, Prof. Anil Gupta) · GI Tags (400+ registered) · IKS Cell at AICTE · Centre of Excellence IIT Kharagpur · NEP 2020 (integrates ITK) · WHO Global Traditional Medicine Centre, Jamnagar (2022). |
| International Instruments | CBD 1992 (Article 8j) · Nagoya Protocol 2010 · UNDRIP 2007 (Article 31) · TRIPS (conflict with CBD — disclosure issue) · UNESCO LINKS Programme · WIPO IGC · WIPO GRATK Treaty 2024. |
| TRIPS-CBD Conflict | TRIPS: No TK disclosure requirement in patents. CBD/Nagoya: Requires PIC + ABS. India advocates TRIPS amendment for mandatory TK source disclosure. WIPO Treaty 2024 addresses this at WIPO level; WTO/TRIPS conflict remains. |
Trap 1 — "TKDL was established by the Ministry of External Affairs" → WRONG! TKDL was established jointly by the Department of Indian Systems of Medicine & Homoeopathy (now Ministry of AYUSH) and CSIR. This was directly tested in UPSC 2014. MEA has no role in TKDL. The AYUSH link makes sense — TKDL documents Ayurvedic, Unani, Siddha, Yoga, and Naturopathy knowledge, which fall under AYUSH's mandate.
Trap 2 — "TKDL covers only Ayurveda, Unani, and Siddha" → WRONG! TKDL also covers Yoga and Naturopathy. The Yoga documentation is particularly important — foreign entities (especially in the USA) filed hundreds of patents on yoga postures, claiming them as novel inventions. TKDL's Yoga documentation has been crucial in challenging these bogus patents. Never say TKDL covers only three systems — it covers all five AYUSH systems.
Trap 3 — "The Neem patent case was decided by WIPO directly" → WRONG! The neem patent was challenged at the European Patent Office (EPO) — not WIPO. WIPO does not have a dispute resolution mechanism for individual patent cases; it sets international standards. Individual patent challenges go to the respective national patent offices (USPTO, EPO etc.). The Turmeric patent was revoked by USPTO. The Neem patent was revoked by EPO. WIPO's role has been at the policy and treaty level — not individual case adjudication.
Trap 4 — "Nagoya Protocol = Convention on Biological Diversity" → WRONG! The Nagoya Protocol is a supplementary agreement to the CBD — NOT the CBD itself. CBD (1992) established the broad framework for biodiversity conservation and benefit-sharing. Nagoya Protocol (2010) operationalised specifically the ABS (Access and Benefit Sharing) mechanism under the CBD, making it legally binding. They are related but distinct instruments. India ratified CBD in 1994 and Nagoya Protocol in 2012 — different dates.
Trap 5 — "The WIPO GRATK Treaty 2024 has fully resolved the biopiracy problem" → WRONG! The treaty, while historic, has significant gaps. It does NOT make non-disclosure of TK source grounds for patent revocation — only disclosure is required. India's proposed modifications were not incorporated. The TRIPS-CBD conflict at WTO level remains unresolved. The Honey Bee Network pointed out that non-disclosure should be grounds for revocation — a key gap. The treaty needs 15 ratifications to enter force. India's own view: "Significant win but certain issues still need careful consideration" (DPIIT statement, May 2024).


